Cataract news - Ophthalmology Times Europe
SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 
Cataract News
  • Paediatric patching not necessary


    Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

    Best phaco disinfection techniques


    Three-day application of levofloxacin in the presence of polyvinyl alcohol-iodine or povidone iodine offers the best infection control in phaco patients, according to a study published in the May 2008 issue of the Japanese Journal of Ophthalmology.

    STAAR lenses granted NTIOL status


    The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid.

    MICS: gauge width impacts wound


    Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

    Oertli launches next generation microincision instruments


    Oertli has launched new instruments to be used in microincision surgery for the anterior and the posterior segments.

    Fourth-generation accommodating IOL gets FDA ok


    The fourth-generation Crystalens HD (Bausch & Lomb) accommodating intraocular lens (IOL) has received FDA marketing approval, five years after the lens was initially launched on the market.

    Alcon and AMO to cross-license IOL patents


    Alcon and Advanced Medical Optics (AMO) are to share proprietary information on their designs for intraocular lenses (IOL).

    Postoperative pain steroid approved


    Durezol (difluprednate ophthalmic emulsion; Sirion Therapeutics) 0.05%, a topical steroid, has received US Food and Drug Administration (FDA) approval for the treatment of postoperative ocular inflammation and pain.

    NSAID activity at trough drug levels


    Animals undergoing lens removal surgery were treated with non-steroidal anti-inflammatory drugs pre- and postoperatively. On the first day after surgery, aqueous humor samples were taken at times corresponding to trough drug levels. The mean aqueous prostaglandin E2 concentration was significantly lower in animals being treated with ketorolac 0.4% (Acular LS, Allergan) compared with those receiving bromfenac 0.09% (Xibrom, ISTA Pharmaceuticals).

Click here